Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-08-21
DOI
10.1093/ijnp/pyac053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges and hopes for Alzheimer’s disease
- (2022) Suren A. Tatulian DRUG DISCOVERY TODAY
- Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial
- (2021) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
- (2021) Yu-Jung Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- History in perspective: How Alzheimer's Disease came to be where it is?
- (2021) Tehniat F. Ahmed et al. BRAIN RESEARCH
- Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia
- (2021) Chieh-Hsin Lin et al. JAMA Network Open
- An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
- (2021) Magdalena Orzylowski et al. Frontiers in Psychiatry
- Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma
- (2020) Kayoung Kim et al. Nature Communications
- d-glutamate and Gut Microbiota in Alzheimer’s Disease
- (2020) Chun-Hung Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical significance of fluid biomarkers in Alzheimer’s Disease
- (2020) Piotr Lewczuk et al. Pharmacological Reports
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
- (2020) Gill Livingston et al. LANCET
- An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
- (2020) Eugene Lin et al. Frontiers in Bioengineering and Biotechnology
- d-serine in physiological and pathological brain aging
- (2020) E. Ploux et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Therapeutic strategies targeting amyloid-β in Alzheimer’s disease
- (2019) Lídia Pinheiroa et al. Current Alzheimer Research
- The development of Kraepelin’s mature diagnostic concept of hebephrenia: a close reading of relevant texts of Hecker, Daraszkiewicz, and Kraepelin
- (2019) Kenneth S. Kendler MOLECULAR PSYCHIATRY
- The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
- (2019) Chieh-Hsin Lin et al. Frontiers in Pharmacology
- Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
- (2019) Chieh-Hsin Lin et al. Frontiers in Psychiatry
- D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment
- (2019) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
- (2019) Chieh-Hsin Lin et al. Scientific Reports
- D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?
- (2018) Paul J. Harrison BIOLOGICAL PSYCHIATRY
- DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia
- (2018) Simona Keller et al. Scientific Reports
- Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
- (2018) Caroline Madeira et al. Frontiers in Psychiatry
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
- (2017) Chieh-Hsin Lin et al. Scientific Reports
- Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
- (2017) Lulu Yao et al. NEURAL PLASTICITY
- Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
- (2016) Esra Soydaş Akyol et al. ACTA NEUROPSYCHIATRICA
- G72 primate-specific gene: a still enigmatic element in psychiatric disorders
- (2016) Silvia Sacchi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Regulating levels of the neuromodulatord-serine in human brain: structural insight into pLG72 andd-amino acid oxidase interaction
- (2016) Leila Birolo et al. FEBS Journal
- Decreased mRNA expression for the two subunits of system xc−, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia
- (2016) Chieh-Hsin Lin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Recent global trends in the prevalence and incidence of dementia, and survival with dementia
- (2016) Martin Prince et al. Alzheimers Research & Therapy
- Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker
- (2016) Esra Soydaş Akyol et al. ACTA NEUROPSYCHIATRICA
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
- (2014) Chun-Yuan Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
- (2013) C-H Lin et al. MOLECULAR PSYCHIATRY
- Genetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72
- (2012) Mechelli Andrea et al. CURRENT PHARMACEUTICAL DESIGN
- Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model
- (2012) Michaela D. Filiou et al. JOURNAL OF PSYCHIATRIC RESEARCH
- System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS
- (2011) Richard J Bridges et al. BRITISH JOURNAL OF PHARMACOLOGY
- D-Amino acid oxidase controls motoneuron degeneration through D-serine
- (2011) J. Sasabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
- (2009) Mark P. Mattson Annals of the New York Academy of Sciences
- pLG72 Modulates Intracellular D-Serine Levels through Its Interaction with D-Amino Acid Oxidase
- (2008) Silvia Sacchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation